KathleenBMullinMD

Neurology • Stamford, CT

Headache

Neurology at Mount Sinai

Join to view full profile

Dr. Mullin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mullin's full profile

Already have an account?

Office
30 Buxton Farm Road
Ste. 230
Stamford, CT 06905
Phone+1 203-914-1900

Fax+1 203-914-1907
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2008 - 2011
Westchester Medical CenterInternship, Internal Medicine, 2007 - 2008
New York University School of MedicineClass of 2007

Certifications & Licensure

NY State Medical License 2008 - 2025
CT State Medical License 2018 - 2024
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesHeadache Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

43 citations
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
Kathleen Mullin, David Kudrow, Robert Croop, Meghan Lovegren, Charles M. Conway, Vladimir Coric> ;Neurology. 2020 May 19
Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
Herold C, Hooli BV, Mullin K, Liu T, Roehr JT, Mattheisen M, Parrado AR, Bertram L, Lange C, Tanzi RE> ;Mol. Psychiatry. 2016-11-01
Rare autosomal copy number variations in early-onset familial Alzheimer's disease.
Hooli BV, Kovacs-Vajna ZM, Mullin K, Blumenthal MA, Mattheisen M, Zhang C, Lange C, Mohapatra G, Bertram L, Tanzi RE> ;Mol. Psychiatry. 2014-06-01
6 citations
Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
Paul Mathew, Jelena M. Pavlovic, Alyssa Lettich, Rebecca Erwin Wells, Carrie E. Robertson, Kathleen Mullin, Larry Charleston, David W. Dodick, Todd J. Schwedt> ;Headache. 2014 Apr 1
No association between marker D10S1423 and Alzheimer's disease.
Bertram L, Saunders AJ, Mullin K, Sampson A, Moscarillo TJ, Basset SS, Go RCP, Blacker D, Tanzi RE> ;Mol. Psychiatry. 2003-06-01
Join now to see all

Lectures

Headache in Children: Identification and Management
Icahn School of Medicine at Mount Sinai, New York, New York - 4/20/2013

Press Mentions

Zavzpret (Zavegepant) Migraine Nasal Spray from Pfizer Gets FDA NodMarch 14th, 2023
Migraine Nasal Spray from Pfizer Snags FDA Approval for Expected Summer LaunchMarch 11th, 2023
FDA Approves Pfizer's Nasal Spray Zavegepant for MigrainesMarch 10th, 2023
Join now to see all

Hospital Affiliations

Stamford HealthStamford, Connecticut